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Objective: To investigate the imipenem and metronidazole resistance profiles of Bacteroides fragilis group strains in 
fecal samples and to detect the resistance genes (ccrA and nim) coding for imipenem and metronidazole resistance in 
B. fragilis group strains. 
Methods: In total, 925 fecal samples, 729 from consecutive diarrhea patients and 196 from healthy controls, were 
collected at Huddinge University Hospital in 1997. A modified disk diffusion method was employed to screen for 
imipenem-resistant and metronidazole-resistant B. fragilis group strains. In strains considered resistant by the modified 
disk diffusion method, the minimum inhibitory concentrations (MICs) were further determined by the agar dilution 
method. PCR assays were used to detect the carbapenem-hydrolyzing metallo-/34actamase gene (ccrA) and the 5- 
nitroimidazole resistance genes h i m )  in pure cultures (purePCR), directly from fecal samples through direct broth 
enrichment (dirPCR) and by immunomagnetic separation (imsPCR). 
Results: Two imipenem-resistant B. fragilis strains, one of which was simultaneously resistant to metronidazole, and 
two B. fragilis group strains with MICs near the breakpoint for metronidazole resistance, were isolated from the fecal 
samples of diarrhea patients. The ccrA gene was identified in all the imipenem-resistant B. fragih strains by purePCR, 
dirPCR and imsPCR. The nim genes were-also detectable by these PCR assays. 
Conclusions: The incidences of imipenem-resistant and metronidazole-resistant B. fragilis group strains were low in 
the investigated diarrhea patients. Simultaneous resistance to imipenem and metronidazole is of great concern in clinical 
medicine, and the proposed PCR assays may be useful in epidemiologic studies of distribution of resistance genes in 
the fecal microflora. 
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INTRODUCTlON 
Bacteroidesjagilis group strains constitute the major part 
of the intestinal microflora [l]. They are the micro- 
organisms most ofien isolated fiom patients with 
anaerobic infections and among the most resistant of all 
anaerobes to antimicrobial agents [2,3]. Imipenem and 
metronidazole are two of the most active antimicrobial 
agents against the B. fiagilis group [MI. Although 
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rare, resistance to imipenem or metronidazole among 
clinical isolates of the B. jagilis group exists [3,5, 
The primary mechanism for resistance to p-lactam 
agents is production of p-lactamases. Carbapenem- 
hydrolyzing metallo-P-lactamase plays an important 
role in the imipenem resistance of B.jagilir ‘strains. This 
enzyme production is encoded by urA (or &A) [3,11]. 
A PCR technique has been established to detect the 
metallo-P-lactamase gene (mA) in pure cultures of B. 
fiagilis strains [12]. Stool samples are some of the most 
di&cult specimens on which to perform PCR, due to 
the presence of multiple substances that inhibit the 
activity of polymerase [13,14]. Recently, in the case of 
enterotoxigenic B. jagilis (ETBF), a culture method 
was used by Pantosti et al  to prepare fecal samples for 
PCR analysis [15], and an imsPCR assay, based on 
immunomagnetic separation (IMS) in combination 
with PCR, was developed by Zhang and Weintraub 
[16] to detect the enterotoxin gene. 
7-9, lo]. 
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5-Nitmimidazole (metronidazole) resistance appears 
to be caused by a combination of decreased antibiotic 
uptake and decreased nitroreductase activity [3]. It 
has been demonstrated that the nim genes coder a 
moderate level of resistance to metronidazole on 
Bacteroides spp. s t r a i n s  [9,17]. A PCR method has been 
developed by Trinh and Reysset for detection of the 
nim genes ( n i d ,  nimB, nimC and nimD) encoding 5- 
nitmimidazole mistance in Barteroides spp. The expected 
w e n t  was obtained by PCR from Batteroides strains 
with MICs of 4-32 mg/L [18]. 
In the present study, we investigated the imipenem 
and metronidazole resistance profiles of B. j u g i k  group 
strains in fecal samples and described the use of PCR 
to detect the metallo-P-lactamase gene (ad) and the 
5-nitro~dazole resistance genes (nim) in pure cultures 
@urePCR), directly h m  fecal samples through direct 
broth enrichment (dirPCR) and by IMS. 
MATERIALS AND MEMODS 
Fecal samplas 
Fecal samples h m  729 consecutive diarrhea patients 
and 196 healthy controls were collected at Huddinge 
University Hospital in 1997. 
Selective media and culture conditions 
The collected fecal samples were h z e n  at -7OOC until 
use. One cotton swab of thawed specimen was 
suspended in 1 mL of nutrient broth. Four drops 
(-200 pL) of the fecal solutions were inoculated in 
4.5 mL of prereduced peptone yeast glucose (PYG) 
broth containing kanamycin (800 mg/L) and incubated 
at 37OC for 48 h. After incubation, the samples were 
processed by a moMed disk diffUsion method. A swab 
of sample from the enrichment broth was streaked 
onto blood-kanamycin-vancomycin (BKV; kanamycin 
100 mg/L, vancomycin 7.5 mg/L) plates. Imipenem 
and metronidazole disks (lOpg/disk; AB Biodisk, 
Solna, Sweden) were applied on the plates, which were 
incubated anaerobically (BBL GasPak Anaerobic System, 
CockeysviUe, MD, USA) at 37°C for 48 h. Colonies 
resistant to imipenem (€2: diameter <13 mm) or 
metronidazole (€2: no inhibition zone) were sub- 
cultured on blood agar plates and identified by Gram- 
fermentation tests [ 191. 
Staining, p-liquid chromatography (GLC) and 
Antimicrobial susceptibilii tests 
The minimum inhibitory concentrations (MICs) of 
imipenem and metronidazole were determined by the 
agar dilution method on ASM agar (AB Biodisk, Solna, 
Sweden) with addition of 5% defibrinated horse blood. 
The inoculum was approximately lo5 CFUIspot, 
applied by a Steer's replicator, and the strains were 
incubated for 48 h at 37OC in anaerobic jars (BBL 
GasPak Anaerobic System, Cockeysvilie, MD, USA) 
[ 191. The agar dilution method employed was generally 
in accordance with the National Committee for 
Clinical Laboratory Standards (NCCLS) [20], except 
that ASM blood agar instead of Brucella blood agar was 
used. Breakpoints used for imipenem (S S4 mg/L, R 
216 mg/L) and for metronidazole (S 1 8  mg/L, R 
232 mg/L) were accordmg to the NCCLS [20]. 
Detection of ccrA and nim genes by PCR 
DNA extraction 
1. DNA extraction from pure bacterial colonies 
@urePCR). One loop (1-2pL) of bacteria was 
picked from an agar plate, suspended in 100 pL of 
MilliQ water, and heated at 95OC for 15 min. 
Following centrifugation (10 0o0g X 5 min) to move 
cell debris, the supernatant containing the DNA was 
stored at -2OOC until use. 
2. DNA extraction directly h m  PYG broth (dirPCR). 
The fecal samples were processed as described 
above. The PYG broth (-4.7 mL) was then centri- 
fuged at 600 rev/& for 10 min to remove fecal 
debris. The Supernatant was M e r  centrifuged at 
4000rev/min for another 10 min. The pellet was 
suspended in 120 pL ofMilliQ water. The following 
procedures were the same as in step 1. 
3. DNA e k c t i o n  h m  PYG broth by use of IMS 
(imsPCR). Following two-step centrifugation as 
described above, the pellet was suspended in 80 pL 
of phosphate-buffered saline (PBS) for incubation 
with magnetic beads. IMS was done according to 
the method of Zhang and Weintraub [16], with 
minor modifications. The magnetic beads, Dyna- 
beads M-450 and Dynabeads M-280 (Dynal, Oslo, 
Norway), were washed according to the manu- 
facturer's recommendations. Then, 18 pg of MAb 
C3 [16] was mixed with 375 pL of Dynabeads M- 
450, and 30 pg of MAb 4H8 [16] was mixed with 
375 pL of Dynabeads M-280. The volumes were 
adjusted to 4000pL by PBS with 0.1% bovine 
serum albumin (BSA), and the beads were incubated 
overnight with bidirectional rotation at 4OC. The 
coated beads were washed by PBS containing 0.05% 
Tween-20 (Merck, Schuchardt, Munich, Germany), 
and were resuspended in 2250 pL of PBS with 0.1% 
BSA. Seventy-five microliters each of the above 
coated beads solution was added to each well of a 
96-well mimtiter plate (Techne, Cambridge, UK). 
With the aid of the magnetic separator (Beadprep 
96; Techne), the magnetic beads were incubated 
with the added sample. The beads with bound 
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bacteria were suspended in 100 pL of MilliQ water 
and processed as in step 1 to extract the DNA. 
Amplification of ccrA 
Primers P1 (5’-AAA GAA TAA AAT GAA AAC 
3’) directed to the mA gene were used [12]. The same 
amplification parameters as described previously were 
employed, except that varying amounts of DNA &om 
steps 1 , 2  and 3 were added in a final volume of 25 pL 
of PCR mixture. The expected product was a DNA 
w e n t  with a length of 442 bp. 
AGT-3’) and P2 (5’-CAG TGA ATC GGT GAA TC- 
Amplification of nim 
Primers NIM3 (5’-ATG TTC AGA GAA ATG CGG 
CGT AAG CG-3’) and NIM5 (5’-GCT TCC TTG 
CCT GTC ATG TGC TC-3’) directed to the nim 
genes were used [18]. Amplification reactions were 
performed in a volume of 50 pL containing 5 pL, 0.5 
pL and 0.1 pL of DNA templates in dirPCR, imsPCR 
and purePCR, respectively, 1.5 mM MgC12, 5 pL of 
X10 Taq buffer (Perkin Elmer AB, Stockholm, 
Sweden), 200 pM each of deoxyadenosine triphos- 
phate, deoxycytidine triphosphate, deoxyguanosine 
triphosphate, and deoxythymidine triphosphate 
(Pharmacia Biotech, Uppsala, Sweden), 1 pM of each 
primer (GibcoBRL, Life Technologies AB, Taby, 
Sweden), and 0.5 U of AmpliTaq polymerase (Perkin 
Elmer AB, Stockholm, Sweden). Cycling parameters 
were as follows: an initial denaturation at 94OC for 10 
min; 30 cycles of 94OC for 30 s, 62°C for 1 min and 
72°C for 1 min; and a final extension at 72OC for 10 
min. The expected product was a DNA w e n t  with 
a length of 458 bp. 
Agarose gel electrophoresis 
The amplified products were subjected to electro- 
phoresis in a 2% agarose gel containing ethidium 
bromide (0.25 mg/L) and photographed under W 
illumination by using the Polaroid MP4 system. A D- 
15 DNA marker (NOVEX, San Diego, Ca, USA) was 
used as a molecular size standard. 
Preparation of spiked fecal samples for PCR analysis 
A stool sample was obtained fhm a healthy volunteer. 
B. 3agiZis KSB 1468/90 [10,12] was used as a mA- 
positive reference strain. Bacteria were suspended 
in PBS to achieve an optical density at 600nm of 
1.0 (approximately 2 X  lo9 CFU/mL). Serial 10-fold 
dilutions were prepared and added to preweighed stool 
samples to attain concentrations ranging &om 10 to 
l o 9  CFU/g of feces. A non-spiked fecal sample 
(0.1 g/mL in PBS) and a pure bacterial suspension in 
PBS (lo8 CFU/mL) were included as negative and 
positive controls, respectively. The spiked fecal samples 
were processed by two methods (dirPCR and imsPCR) 
to determine the sensitivity of each assay. B. uni$ormis 
2935 isolated in this study was used to spike the stool 
sample to determine the sensitivity of dirPCR for nirn 
in t h i s  strain. 
Resistant strains 
Among the 925 fecal samples, two imipenem-resistant 
B: jiagilis strains (B. 3agilis 603 and 1619) and six 
metronidazole-resistant B. jiagilis group strains (B. 
distasonis 782 and 3667, B. fiagilis 1619, B. thetaiotao- 
micron 2877, B. uni$omis 2935 and B. vulgatus 2985) 
were detected by the modified disk a s i o n  method 
(Table 1). B.fiagilis 1619 was simultaneously resistant to 
imipenem and metronidazole. The MICs for imipenem 
and metronidazole of these strains were further 
determined by the agar dilution method (Table 1). B. 
fiagilis 603 and 1619 were highly resistant to imipenem, 
with MICs >32 mg/L. Among the metronidazole- 
Table 1 Resistant strains detected by the modified disk *ion method, their MICs by the agar dilution method and 
detection of resistance genes 
~ _ _ _ _ _ _ _ _ _ _  _______~ 
MICs (mg/L) Presence of 
resistance genes Modified disk &ion method 
Imipenem Metronidazole Imipenem Metronidazole mA nim’ 
Agar dilution method 
- Bacteroiderjagilis 603 R S > 32 0.5 + 
B.fmgilis 1619 R R > 32 32 + 
B. un$onnis 2935 S R 0.25 1 
B. vulgatus 2985 S R 0.25 8 
- - B. distaronis 782 S R 1 0.5 








- - B. distaronis 3667 s R 2 0.5 
R, resistant; S, susceptible. 
‘Detected by purePCR. 
7 56 Clinical Microbio logy and Infection, Volume 5 N u m b e r  1 2 .  
resistant strains detected by the modified disk &ion 
method, only one of them (B. jugi l i s  1619) was 
regarded as resistant by the MICs according to the 
NCCLS [20]. 
Detection of ccrA in Bactemides h@/is strains 
The metallo-blactamase gene ccrA was detected from 
samples 603 and 1619 by all three methods @urePCR, 
dirPCR and imsPCR). The amount of DNA required 
for optimal amplification varied with different methods 
and different strains. Sample 603 was used as an 
example (Figure 1). For dirPCR, though with varying 
intensity, PCR products with an expected length of 
442 bp were yielded when 1 pL, 5 pL or 15 pL of DNA 
was included in the reaction mixture. For imsPCR, 
positive reactions were obtained with 0.1 pL, 1 pL, 
5 pL or 10 pL of DNA. For purePCR, an intensive 
band at the position of 442 bp was observed with 1 pL 
of DNA. 
Ssnsitiviiw of dirPCR and imsPCR for detection of 
ccrA from spiked fecal samples 
The sensitivities of the dirPCR assay and imsPCR assay 
were investigated by use of spiked fecal samples. The 
limits for the detection of cnA by dirPCR and imsPCR 
were -lo5 CFU/g of feces and -104-105 CFU/g of 
feces, respectively (Figures 2 and 3). For dirPCR, 
the lower limits of detection with 1 pL, 5 pL or 15 pL 
of DNA were lo’, lo5 and lo6 CFU/g of feces, 
respectively. The most sensitive reaction was obtained 
with 5 pL of DNA in the reaction mixture (Figure 2). 
For imsPCR, the suitable amount of DNA in the 
reaction mixture was 0.1 pL (Figure 3). 
1 2 3 4 5 6 7 8 9 1 0 1 1 1 2  
Figure 2 The dirPCR products of ccrA from spiked fed 
samples prepared with serial dilutions of B. MZb KS3 
1468/90. Lane 1: negative control. Lane 2 positive control. 
Lanes 3-1 1: dilutions &om 10 to lo9 CFU/g of feces, 
respectively. Lane 12: DNA molecular size markex. 
1 2  3 4 5 6 7 8 9 1 0 1 1 1 2  
Figure 3 The imsPCR products of caA from spiked f e d  
samples prepared with serial dilutions of B. fi.ailis KSB 
1468/90. Lane 1: negative control. Lane 2 positive control. 
Lanes 3-11: dilutions firom 10 to 109 CFWg of feces, 
respectively. Lane 12: DNA molecular size marker. 
1 2  3 4 5 6 7 8 9 1 0 1 1 1 2 1 3  
Detection of n h  genes in Bacteroides hgi/lir group strains 
Among the six metronidazole-resistant B. jag& p u p  
strains detected by the modified disk *ion method, 
1 2 3 4 5 6 7 8 9  
Figure 4 Agarose gel electrophoresis of PCR products for 
detection of nim. Lanes 1 and 13: DNA molecular size 
marker. Lane 2: negative control. Lane 3: positive control. 
Lane 4 sample 1619 by imsPCR. Lanes 5-8: B.fiagiIir 
1619, B. vulgafus 2985, B. uniformmis 2935 and B. 
thetaiotnomimn 2877 by purePCR. Lanes 9-12 samples 
1619,2985,2935 and 2877 by dirPCR. 
Figure 1 Agarose gel electrophoresis of PCR products 
from sample 603 for detection of arA. Lane 1: purePCR 
1 pL and 0.1 pL of DNA, respectively. Lanes 6-8: dirPCR 
with 15 pL, 5 pL and 1 pL of DNA, respectively. Lane 9: 
DNA molecular size marker (D-15 DNA marker; 
NOVEX, San Diego, Ca, USA). 
with 1 pL of DNA. Lane 2-5: imsPCR with 10 pL, 5 pL, 
the nim genes were detected by dirPCR fiom samples 
1619, 2877 and 2985, by imsPCR from sample 1619, 
and by purePCR in strains B. thetaiotaomicron 2877, B. 
unqomis 2935 and B. awlgatus 2985, but not in B.jugilis 
1619 (Figure 4 and Table 1). The lower limit for 
detection of nim by the dirPCR assay from fecal samples 
spiked with B. un$mis 2935 was lo8 CFU/g of feces. 
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DISCUSSION 
In this study, two stra ins (B.jagilis 603 and 1619) were 
considered to be resistant to imipenem and one s t r a i n  
(B. jagilis 1619) to metronidazole according to their 
MICs. They were isolated from fecal samples of 
diarrhea patients. The rates of imipenem-resistant and 
metronidazole-resistant B. jagilis group strains in 
diarrhea patients examined were 0.27% (2/729) and 
0.14% (1/729), respectively. The incidence ofresistance 
to imipenem or metronidazole in B. jagilis group 
strains was low in this survey, which is in accordance 
with other surveys [ M I .  One isolate (B.jagilis 1619) 
was found to be resistant to both imipenem and 
metronidazole. It was isolated h m  the fecal sample of 
a 24-year-old female patient with diarrhea. Besides B. 
jugilis 1619, Clostridium sp. was isolated on the BKV 
plate from this sample. Simultaneous resistance to 
imipenem and metronidazole in B.jugifis is unusual. B. 
jagilis KSB 1468/90 reported previously was this kind 
of multiresistant strain which was isolated from the 
blood of a patient with septicemia [lo], and in a report 
by Turner et al in 1995 a similar strain was described 
[7]. Since options for the treatment of B. jagif is  are 
limited [21], the appearance ofmultiresistant strains will 
give rise to a rehctory problem in clinical medicine. 
The modified disk difhsion method-was employed 
to screen for resistant st ra ins .  The detected imipenem- 
resistant st ra ins  had high MICs (>32 mg/L) as deter- 
mined by the agar dilution method. The results of these 
two methods were in agreement in the case of 
imipenem. When confirming the metronidazole 
resistance by the agar dilution method, only one strain 
(B. jagilis 1619) reached the breakpoint (32 mg/L) in 
terms of MIC, and two strains (B. thetaiotaorninon 2877 
and B. vulgatus 2985) had MICs near the breakpoint 
(Table 1). Several factors may be responsible for the 
discrepancy between these two methods. The number 
of microorganisms in feces and the dilution of micro- 
organisms in loose or watery stools can lead to a varying 
inoculum in the modified disk &sion method. It is 
also known that Bacteroides species can be protected 
against the f i g  effect of metronidazole in the presence 
of Enterococnrsfaecalis [22,23]. Although &Icteroides strains 
were enriched after PYG broth incubation, the bacteria 
applied to the plate in this assay s t i l l  comprised a mixed 
culture. This might be the reason why the number of 
resistant s t r a i n s  detected by the modified disk *ion 
method was higher than the number of resistant strains 
confirmed by the agar dilution method. In any case, the 
modified disk a s i o n  method used in the present 
study was a practical and effective screening method 
when dealing with large numbers of samples. 
The carbapenem-hydrolyzing metallo-P-lactamase 
gene (cnA) was detected from samples 603 and 1619 by 
purePCR, dirPCR, and imsPCR. The amount of 
DNA required for each assay is different, which reflects 
the difference in the concentration of DNA obtained 
by different processing methods, the percentage of 
target DNA in the whole DNA extracted, and the copy 
number of the target gene. In principle, anaerobes were 
enriched, aerobes were idubited and PCR inhibitors 
h m  feces were diluted after incubation in PYG broth 
containing kanamycin (dirPCR). Therefore, the DNA 
used in dirPCR was mainly nucleic acid h m  mixed 
anaerobes. In imsPCR, only B. jugilis st ra ins  were 
included, since the monoclonal antibodies (MAb C3 
and MAb 4H8) used in the IMS were specific for the 
lipopolysaccharides of B. jugifis [16]. 
For detection of mA, PCR with spiked fecal 
samples (B.jugilis KSB 1468/90) showed that there was 
at most one log difference in the lower limits of 
detection between imsPCR (104-105 CFU/g of feces) 
and dirPCR (lo5 CFU/g of feces). 
The nirn gene was detected from sample 1619 by 
dirPCR and imsPCR, but not by purePCR. The 
metronidazole-resistant strain B. jagifis 1619 isolated 
from this sample did not yield amplicon by purePCR, 
which indicates absence of the nirn gene or that the nim 
gene is undetectable by the employed PCR assay. One 
explanation of the positive results in dirPCR and 
imsPCR in sample 1619 might be the presence of B. 
jagifis strains other than B.jagilis 1619, containing the 
nim gene. For sample 2935, the nim gene was detected 
in purePCR, but not in dirPCR. Further studies using 
spiked fecal samples showed that the limit for detection 
of nim by dirPCR in this strain was lo8 CFU/g offeces. 
Therefore, it is believed that the concentration of B. 
unijbrmis 2935 in the sample was lower than this limit. 
Since the IMS method used in this study was specific 
for B.jagilis only, the imsPCR assay was not applied to 
non-jagilis species of the B. jagifis group. The nim 
genes were also detected in samples 2877 and 2985 
( s t r a i n  2877 and strain 2985, MIC 8mg/L for 
metronidazole), by bath pure PCR and dirPCR, but 
not in samples 603, 782 and 3667 (MIC for metro- 
nidazole 0.5 mg/L). The metronidazole susceptibilities 
were further determined by disk difbsion from the 
isolated strains. There was no inhibition zone for s t r a i n s  
with MICs 8-32 mg/L. As we know, the breakpoint 
for metronidazole susceptibility is 5 4  mg/L in Spain 
and France, and the breakpoint for metronidazole 
resistance is 216 mg/L in Sweden. According to the 
present findings, regarding the presence of nim genes 
(strains with MICs 2 1 mg/L), the NCCLS breakpoint 
for metronidazole might be too high. 
The dirPCR assay is simpler but somewhat less 
sensitive than the imsPCR assay for the detection of 
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ccrA fiom fecal samples. The dirPCR assay is not 
limited by the specificity of the monoclonal antibodies, 
which makes it applicable not only to B. jagilk species 
but also to other bacterial species. Both methods are 
h e  of complexity of isolation and identification of the 
microorganism among the complex fecal bacterial 
flora. 
In conclusion, the incidences of itnipenem-resistant 
and metronidazole-resistant B. jagilk group strains 
were low in the investigated diarrhea patients. Simul- 
taneous resistance to imipenem and metronidazole is of 
great concern in clinical medicine. Resistance genes 
can be detected fiom fecal samples without pure 
bacterial isolates. This may be usell in epidemiologic 
studies of the distribution of resistance genes in the fecal 
miCrOflOOra. 
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